Open Access

Clinical-radiological features and oxidative stress in patients with community-acquired pneumonia and heart failure

Virginia Cascaval

Virginia Cascaval

Department of Internal Medicine, “Nicolae Testemitanu” State University of Medicine and PharmacyChisinau, Republic of Moldova
Search for this author on
Sciendo|Google Scholar
Cascaval, Virginia
, 
Tatiana Dumitras

Tatiana Dumitras

Department of Internal Medicine, “Nicolae Testemitanu” State University of Medicine and PharmacyChisinau, Republic of Moldova
Search for this author on
Sciendo|Google Scholar
Dumitras, Tatiana
, 
Diana Fetco-Mereuta

Diana Fetco-Mereuta

Department of Internal Medicine, “Nicolae Testemitanu” State University of Medicine and PharmacyChisinau, Republic of Moldova
Search for this author on
Sciendo|Google Scholar
Fetco-Mereuta, Diana
, 
Sergiu Matcovschi

Sergiu Matcovschi

Department of Internal Medicine, “Nicolae Testemitanu” State University of Medicine and PharmacyChisinau, Republic of Moldova
Search for this author on
Sciendo|Google Scholar
Matcovschi, Sergiu
, 
Livi Grib

Livi Grib

Department of Internal Medicine, “Nicolae Testemitanu” State University of Medicine and PharmacyChisinau, Republic of Moldova
Search for this author on
Sciendo|Google Scholar
Grib, Livi
 and 
Cornelia Talmaci

Cornelia Talmaci

Department of Internal Medicine, “Nicolae Testemitanu” State University of Medicine and PharmacyChisinau, Republic of Moldova
Search for this author on
Sciendo|Google Scholar
Talmaci, Cornelia
  
Apr 16, 2025
Clinical-radiological features and oxidative stress in patients with community-acquired pneumonia and heart failure's Cover Image
About this article
Previous Article
Next Article
Cite
Download Cover
Article Category: Pneumologia
Published Online: Apr 16, 2025
Page range: 1 - 7
DOI: https://doi.org/10.2478/pneum-2025-0001
Keywords
© 2024 Virginia Cascaval et al., published by Sciendo
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.

Figure 1.

Total AAT with CUPRAC method in patients with CAP and CHF. AAT, antioxidant activity; CAP, community-acquired pneumonia; CHF, chronic heart failure.
Total AAT with CUPRAC method in patients with CAP and CHF. AAT, antioxidant activity; CAP, community-acquired pneumonia; CHF, chronic heart failure.

Comparison of OS markers in patients with CAP and CHF_

Parameters Group 1 (n = 105) Group 2 (n = 105) F P
Mean SD± Mean SD±
AIM (μM/L) 229.7775 57.23919 236.6077 64.35578 0.660 0.417
AGE-pentosidine-like (μM/L) 598.7908 251.68051 544.5575 197.20439 3.021 0.084
AGE-verperlisin-like (μM/L) 449.1497 169.38287 455.2475 160.66932 0.072 0.789
PPOA (μM/L) 95.2128 63.05108 105.9567 55.21101 1.726 0.190
Catalase (μM/L) 21.8819 10.01078 23.1646 11.54527 0.740 0.391
AAT with CUPRAC (μM/L) 6.7012 4.62461 4.9987 4.29101 7.647 0.006
AAT with ABTS (μM/L) 132.2233 21.48573 128.2355 22.21592 1.748 0.188
SOD (u/c) 62.7206 13.37431 62.3362 16.47029 0.034 0.853
MDA (μM/L) 17.4629 6.94660 16.0739 4.72922 2.869 0.092

Concomitant diseases in patients with CAP and CHF_

Group 1 (n = 105) Group 2 (n = 105) P, df = 1
Abs. % Abs. %
Dyslipidaemia 20 19.0 16 15.2 χ2 = 0.536; P = 0.464
Chronic liver disease 13 12.4 8 7.6 χ2 = 1.323; P = 0.250
Atrial fibrillation 54 51.4 0 0 χ2 = 72.692; P < 0.0001
Arterial hypertension 103 98.0 84 80.1 χ2 = 19.552; P < 0.0001
Chronic kidney disease 21 20.0 6 5.7 χ2 = 9.563; P = 0.002
Type 2 diabetes mellitus 41 39.0 25 23.8 χ2 = 5.657; P = 0.017
Cerebrovascular disease 47 44.8 25 23.8 χ2 = 10.229; P = 0.001
Language:
English
Publication timeframe:
Volume Open
Journal Subjects:
Medicine, Clinical Medicine, Clinical Medicine, other, Internal Medicine, Pneumology
Journal RSS Feed